Attenuation of proinflammatory responses by S -[6]-Gingerol via inhibition of ROS/NF-Kappa B/COX2 activation in HuH7 cells

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Li, Xiao Hong ^a,b,c   McGrath, Kristine C Y ^a,d   Tran, Van H ^b   Li, Yi Ming ^b   Duke, Colin C ^b   Roufogalis, Basil D ^b   Heather, Alison K ^a,d  

^a HEART RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Dezhou People's Hospital   (China)

^d UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

(6) GINGEROL; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; SERUM AMYLOID A;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LIVER CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84880234919     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/146142     Document Type: Article

References (44)

1. Hotamisligil G. S., Inflammation and metabolic disorders. Nature 2006 444 7121 860 867 2-s2.0-33845866857 10.1038/nature05485
2. Marceau P., Biron S., Hould F.-S., Marceau S., Simard S., Thung S. N., Kral J. G., Liver pathology and the metabolic syndrome X in severe obesity. Journal of Clinical Endocrinology and Metabolism 1999 84 5 1513 1517 2-s2.0-0033329864
3. Cai D., Yuan M., Frantz D. F., Melendez P. A., Hansen L., Lee J., Shoelson S. E., Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nature Medicine 2005 11 2 183 190
4. Ghosh S., May M. J., Kopp E. B., NF- B and rel proteins: evolutionarily conserved mediators of immune responses. Annual Review of Immunology 1998 16 225 260 2-s2.0-0031897632 10.1146/annurev.immunol.16.1.225
5. Christman J. W., Lancaster L. H., Blackwell T. S., Nuclear factor B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Medicine 1998 24 11 1131 1138 2-s2.0-0031755148 10.1007/s001340050735
6. Abd-El-Aleem S. A., Ferguson M. W. J., Appleton I., Bhowmick A., McCollum C. N., Ireland G. W., Expression of cyclooxytenase isoforms in normal human skin and chronic venous ulcers. Journal of Pathology 2001 195 5 616 623 2-s2.0-0035542913 10.1002/path.992
7. Afzal M., Al-Hadidi D., Menon M., Pesek J., Dhami M. S. I., Ginger: an ethnomedical, chemical and pharmacological review. Drug Metabolism and Drug Interactions 2001 18 3-4 159 190 2-s2.0-0035669598
8. Grzanna R., Lindmark L., Frondoza C. G., Ginger-an herbal medicinal product with broad anti-inflammatory actions. Journal of Medicinal Food 2005 8 2 125 132 2-s2.0-22444431608 10.1089/jmf.2005.8.125
9. Jung H. W., Yoon C.-H., Park K. M., Han H. S., Park Y.-K., Hexane fraction of Zingiberis Rhizoma Crudus extract inhibits the production of nitric oxide and proinflammatory cytokines in LPS-stimulated BV2 microglial cells via the NF-kappaB pathway. Food and Chemical Toxicology 2009 47 6 1190 1197 2-s2.0-67349236219 10.1016/j.fct.2009.02.012
10. Frondoza C. G., Sohrabi A., Polotsky A., Phan P. V., Hungerford D. S., Lindmark L., An in vitro screening assay for inhibitors of proinflammatory mediators in herbal extracts using human synoviocyte cultures. In Vitro Cellular & Developmental Biology 2004 40 3-4 95 101
11. Li X.-H., McGrath K. C.-Y., Nammi S., Heather A. K., Roufogalis B. D., Attenuation of liver pro-inflammatory responses by Zingiber officinale via inhibition of NF-kappa B activation in high-fat diet-fed rats. Basic and Clinical Pharmacology and Toxicology 2012 110 3 238 244 2-s2.0-84857363526 10.1111/j.1742-7843.2011.00791.x
12. Oyagbemi A. A., Saba A. B., Azeez O. I., Molecular targets of [6]-gingerol: its potential roles in cancer chemoprevention. BioFactors 2010 36 3 169 178 2-s2.0-77955724097 10.1002/biof.78
13. Tripathi S., Maier K. G., Bruch D., Kittur D. S., Effect of 6-gingerol on pro-inflammatory cytokine production and costimulatory molecule expression in murine peritoneal macrophages. Journal of Surgical Research 2007 138 2 209 213 2-s2.0-33847617069 10.1016/j.jss.2006.07.051
14. Lee C., Park G. H., Kim C.-Y., Jang J.-H., [6]-Gingerol attenuates β -amyloid-induced oxidative cell death via fortifying cellular antioxidant defense system. Food and Chemical Toxicology 2011 49 6 1261 1269 2-s2.0-79955674768 10.1016/j.fct.2011.03.005
15. Li Y., Tran V. H., Duke C. C., Roufogalis B. D., Gingerols of Zingiber officinale enhance glucose uptake by increasing cell surface GLUT4 in cultured L6 myotubes. Planta Medica 2012 78 14 1549 1555
16. Death A. K., McGrath K. C. Y., Sader M. A., Nakhla S., Jessup W., Handelsman D. J., Celermajer D. S., Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor- B-dependent pathway. Endocrinology 2004 145 4 1889 1897 2-s2.0-1642464782 10.1210/en.2003-0789
17. Bustin S. A., Absolute quantification of mrna using real-time reverse transcription polymerase chain reaction assays. Journal of Molecular Endocrinology 2000 25 2 169 193 2-s2.0-0033775615
18. McGrath K. C. Y., Li X. H., Puranik R., Liong E. C., Tan J. T. M., Dy V. M., Dibartolo B. A., Barter P. J., Rye K. A., Heather A. K., Role of 3 β -hydroxysteroid-Δ24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 6 877 882 2-s2.0-66349086768 10.1161/ATVBAHA.109. 184663
19. Anderson G. D., Hauser S. D., McGarity K. L., Bremer M. E., Isakson P. C., Gregory S. A., Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. The Journal of Clinical Investigation 1996 97 11 2672 2679 2-s2.0-0029888972
20. Portanova J. P., Zhang Y., Anderson G. D., Hauser S. D., Masferrer J. L., Seibert K., Gregory S. A., Isakson P. C., Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. Journal of Experimental Medicine 1996 184 3 883 891 2-s2.0-0029787626
21. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., Lee L., Isakson P., Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proceedings of the National Academy of Sciences of the United States of America 1994 91 25 12013 12017 2-s2.0-0027944075 10.1073/pnas.91.25.12013
22. Cho H. K., Cheong K. J., Kim H. Y., Cheong J., Endoplasmic reticulum stress induced by hepatitis B virus X protein enhances cyclo-oxygenase 2 expression via activating transcription factor 4. Biochemical Journal 2011 435 2 431 439 2-s2.0-79953192507 10.1042/BJ20102071
23. Williams C. S., Mann M., DuBois R. N., The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999 18 55 7908 7916 2-s2.0-0033590207
24. Buttar N. S., Wang K. K., The "aspirin" of the new millennium: cyclooxygenase-2 inhibitors. Mayo Clinic Proceedings 2000 75 10 1027 1038 2-s2.0-0033805055
25. Fosslien E., Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia. Critical Reviews in Clinical Laboratory Sciences 2000 37 5 431 502 2-s2.0-0034471496
26. Tilley S. L., Coffman T. M., Koller B. H., Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. The Journal of Clinical Investigation 2001 108 1 15 23 2-s2.0-0034943516 10.1172/JCI200113416
27. Tsutakawa S., Kobayashi D., Kusama M., Moriya T., Nakahata N., Nicotine enhances skin necrosis and expression of inflammatory mediators in a rat pressure ulcer model. British Journal of Dermatology 2009 161 5 1020 1027 2-s2.0-71949099436 10.1111/j.1365-2133.2009.09349.x
28. Yang C., Yang Z., Zhang M., Dong Q., Wang X., Lan A., Zeng F., Chen P., Wang C., Feng J., Hydrogen sulfide protects against chemical hypoxia-induced cytotoxicity and inflammation in hacat cells through inhibition of ROS/NF- B/COX-2 pathway. PLoS ONE 2011 6 7 2-s2.0-79960320543 10.1371/journal.pone. 0021971 e21971
29. Vane J., Towards a better aspirin. Nature 1994 367 6460 215 216 2-s2.0-0028044609 10.1038/367215a0
30. Tseng P.-C., Hsu H.-C., Janmanchi D., Lin C.-H., Kuo Y.-H., Chou C.-K., Yeh S.-F., Helioxanthin inhibits interleukin-1 β -induced MIP-1 β production by reduction of c-jun expression and binding of the c-jun/CREB1 complex to the AP-1/CRE site of the MIP-1 β promoter in Huh7 cells. Biochemical Pharmacology 2008 76 9 1121 1133 2-s2.0-53649095301 10.1016/j.bcp.2008.08.023
31. Kleemann R., Verschuren L., De Rooij B.-J., Lindeman J., De Maat M. M., Szalai A. J., Princen H. M. G., Kooistra T., Evidence for anti-inflammatory activity of statins and PPAR α activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro. Blood 2004 103 11 4188 4194 2-s2.0-2542465868 10.1182/blood-2003-11-3791
32. Kleemann R., Gervois P. P., Verschuren L., Staels B., Princen H. M. G., Kooistra T., Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NF B-C/EBP- β complex formation. Blood 2003 101 2 545 551 2-s2.0-0037438377 10.1182/blood-2002-06-1762
33. El-Tayeh S. F., Hussein T. D., El-Houseini M. E., Amer M. A., El-Sherbini M., Elshemey W. M., Serological biomarkers of hepatocellular carcinoma in Egyptian patients. Disease Markers 2012 32 4 255 263 2-s2.0-84859317010 10.3233/DMA-2011-0883
34. Pearson T. A., Mensah G. A., Alexander R. W., Anderson J. L., Cannon R. O. III, Criqui M., Fadl Y. Y., Fortmann S. P., Hong Y., Myers G. L., Rifai N., Smith S. C. Jr., Taubert K., Tracy R. P., Vinicor F., Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 2003 107 3 499 511 2-s2.0-0037469232 10.1161/01.CIR.0000052939.59093.45
35. Hotamisligil G. S., Inflammatory pathways and insulin action. International Journal of Obesity 2003 27 supplement 3 S53 S55 2-s2.0-0346880504 10.1038/sj.ijo.0802502
36. Arkan M. C., Hevener A. L., Greten F. R., IKK-beta links inflammation to obesity-induced insulin resistance. Nature Medicine 2005 11 2 191 198
37. Roebuck K. A., Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB (Review). International Journal of Molecular Medicine 1999 4 3 223 230 2-s2.0-0033192573
38. Kang S. W., Chae H. Z., Seo M. S., Kim K., Baines I. C., Rhee S. G., Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generatedin response to growth factors and tumor necrosis factor- α The Journal of Biological Chemistry 1998 273 11 6297 6302 2-s2.0-0141746553 10.1074/jbc.273.11.6297
39. Schenk H., Klein M., Erdbrügger W., Dröge W., Schulze-Osthoff K., Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. Proceedings of the National Academy of Sciences of the United States of America 1994 91 5 1672 1676
40. Brigelius-Flohé R., Friedrichs B., Maurer S., Schultz M., Streicher R., Interleukin-1-induced nuclear factor B activation is inhibited by overexpression of phospholipid hydroperoxide glutathione peroxidase in a human endothelial cell line. Biochemical Journal 1997 328 1 199 203 2-s2.0-0030702951
41. Manna S. K., Zhang H. J., Yan T., Oberley L. W., Aggarwal B. B., Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor- B and activated protein-1. The Journal of Biological Chemistry 1998 273 21 13245 13254 2-s2.0-0032557458 10.1074/jbc.273.21.13245
42. Kretz-Remy C., Mehlen P., Mirault M.-E., Arrigo A.-P., Inhibition of I B- α phosphorylation and degradation and subsequent NF- B activation by glutathione peroxidase overexpression. Journal of Cell Biology 1996 133 5 1083 1093 2-s2.0-0029999693
43. Lee R., Beauparlant P., Elford H., Ponka P., Hiscott J., Selective inhibition of I B α phosphorylation and HIV-1 LTR-directed gene expression by novel antioxidant compounds. Virology 1997 234 2 277 290 2-s2.0-0030612264 10.1006/viro.1997.8642
44. Lu X., Kambe F., Cao X., Kozaki Y., Kaji T., Ishii T., Seo H., 3 β -hydroxysteroid-Δ24 reductase is a hydrogen peroxide scavenger, protecting cells from oxidative stress-induced apoptosis. Endocrinology 2008 149 7 3267 3273 2-s2.0-46349096632 10.1210/en.2008-0024